Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-06-12 Option Award |
2025-06-13 4:10 pm |
N/A 2035-06-11 |
Werewolf Therapeutics Inc. | HOWL | EVNIN LUKE Director |
27,000 | $0 | 27,000 (Direct) |
View |
| 2025-03-27 Exercise |
2025-04-30 4:09 pm |
N/A N/A |
Werewolf Therapeutics Inc. | HOWL | EVNIN LUKE Director 10% Owner |
28,113 | $0.09 | 4,309,860 (Indirect) |
View |
| 2025-03-27 Exercise |
2025-04-30 4:09 pm |
N/A 2025-04-09 |
Werewolf Therapeutics Inc. | HOWL | EVNIN LUKE Director 10% Owner |
28,113 | $0 | 4,309,860 (Indirect) |
View |
| 2024-05-24 Option Award |
2024-05-24 7:45 pm |
N/A 2034-05-23 |
Werewolf Therapeutics Inc. | HOWL | EVNIN LUKE Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:53 pm |
N/A 2033-06-20 |
Werewolf Therapeutics Inc. | HOWL | EVNIN LUKE Director |
13,200 | $0 | 13,200 (Direct) |
View |
| 2023-06-01 Other |
2023-06-05 4:36 pm |
N/A N/A |
TCR2 THERAPEUTICS INC. | TCRR | MPM BioVentures 2014 L.P. Foley Todd EVNIN LUKE MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC MPM ASSET MANAGEMENT LLC 10% Owner |
4,158,964 | $0 | 4,158,964 (Indirect) |
View |
| 2023-05-22 Exercise |
2023-05-24 4:39 pm |
N/A N/A |
TCR2 THERAPEUTICS INC. | TCRR | MPM ASSET MANAGEMENT LLC EVNIN LUKE 10% Owner |
178,269 | $0.74 | 3,674,978 (Direct) |
View |
| 2023-05-22 Exercise |
2023-05-24 4:39 pm |
2016-12-13 2026-12-12 |
TCR2 THERAPEUTICS INC. | TCRR | MPM ASSET MANAGEMENT LLC EVNIN LUKE 10% Owner |
178,269 | $0 | 3,674,978 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-24 06:42 am |
N/A 2032-06-23 |
Oncorus Inc. | ONCR | EVNIN LUKE Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 4:42 pm |
N/A 2032-05-31 |
Werewolf Therapeutics Inc. | HOWL | EVNIN LUKE Director |
11,600 | $0 | 11,600 (Direct) |
View |
| 2021-11-17 Other |
2021-11-24 6:34 pm |
N/A N/A |
iTeos Therapeutics Inc. | ITOS | MPM BioVentures 2014 L.P. EVNIN LUKE Foley Todd MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC MPM BIOVENTURES 2018 (B) L.P. MPM ASSET MANAGEMENT INVESTORS BV2018 LLC 10% Owner |
15,671 | $0 | 3,057,536 (Indirect) |
View |
| 2021-11-02 Conversion |
2021-11-04 5:37 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | MPM BioVentures 2014 L.P. EVNIN LUKE GADICKE ANSBERT MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC MPM BIOVENTURES 2018 (B) L.P. MPM ASSET MANAGEMENT INVESTORS BV2018 LLC 10% Owner |
35,626,700 | $0 | 4,425,784 (Indirect) |
View |
Ownership |
2021-10-28 8:45 pm |
N/A N/A |
Entrada Therapeutics Inc. | TRDA | MPM BioVentures 2014 L.P. EVNIN LUKE GADICKE ANSBERT MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC MPM BIOVENTURES 2018 (B) L.P. MPM ASSET MANAGEMENT INVESTORS BV2018 LLC 10% Owner |
0 | $0 | 4,325,784 (Indirect) |
View |
| 2021-09-07 Other |
2021-09-08 7:13 pm |
N/A N/A |
iTeos Therapeutics Inc. | ITOS | MPM BioVentures 2014 L.P. EVNIN LUKE Foley Todd MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC MPM BIOVENTURES 2018 (B) L.P. MPM ASSET MANAGEMENT INVESTORS BV2018 LLC 10% Owner |
31,340 | $0 | 3,623,221 (Indirect) |
View |
| 2021-06-16 Option Award |
2021-06-17 5:56 pm |
N/A 2031-06-15 |
Oncorus Inc. | ONCR | EVNIN LUKE Director 10% Owner |
12,500 | $0 | 12,500 (Direct) |
View |
| 2021-05-04 Conversion |
2021-05-06 4:19 pm |
N/A N/A |
Werewolf Therapeutics Inc. | HOWL | EVNIN LUKE Director 10% Owner |
35,504,612 | $0 | 12,224,142 (Indirect) |
View |
| 2021-04-30 Option Award |
2021-05-03 7:59 pm |
N/A 2031-04-29 |
Werewolf Therapeutics Inc. | HOWL | EVNIN LUKE Director 10% Owner |
23,200 | $0 | 23,200 (Direct) |
View |
| 2021-04-30 Other |
2021-04-30 6:30 pm |
N/A N/A |
TURMERIC ACQUISITION CORP. | TMPM | EVNIN LUKE Chief Executive Officer |
17,500 | $0 | 2,298,750 (Indirect) |
View |
Ownership |
2021-04-29 5:30 pm |
N/A N/A |
Werewolf Therapeutics Inc. | HOWL | EVNIN LUKE Director 10% Owner |
0 | $0 | 4,165,501 (Indirect) |
View |
| 2021-04-07 Other |
2021-04-09 4:10 pm |
N/A N/A |
iTeos Therapeutics Inc. | ITOS | MPM BioVentures 2014 L.P. EVNIN LUKE Foley Todd MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC MPM BIOVENTURES 2018 (B) L.P. MPM ASSET MANAGEMENT INVESTORS BV2018 LLC 10% Owner |
15,670 | $0 | 3,671,576 (Indirect) |
View |